Tsagkaris C, Papadakos SP, Moysidis DV, Papazoglou AS, Koutsogianni A, Papadakis M. Hepatomusculoskeletal disorders: Coining a new term might improve the management of the musculoskeletal manifestations of chronic liver disease. World J Gastrointest Pathophysiol 2022; 13(4): 124-127 [PMID: 36161230 DOI: 10.4291/wjgp.v13.i4.124]
Corresponding Author of This Article
Christos Tsagkaris, MD, Academic Fellow, Public Health and Policy Working Group, Stg European Student Think Tank, Postjeskade 29, 1058 DE, Amsterdam, Netherlands. chriss20x@gmail.com
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Letter to the Editor
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastrointest Pathophysiol. Jul 22, 2022; 13(4): 124-127 Published online Jul 22, 2022. doi: 10.4291/wjgp.v13.i4.124
Hepatomusculoskeletal disorders: Coining a new term might improve the management of the musculoskeletal manifestations of chronic liver disease
Christos Tsagkaris, Stavros P Papadakos, Dimitrios V Moysidis, Andreas S Papazoglou, Alexandra Koutsogianni, Marios Papadakis
Christos Tsagkaris, Public Health and Policy Working Group, Stg European Student Think Tank, Amsterdam, Netherlands
Stavros P Papadakos, Alexandra Koutsogianni, Laiko General Hospital of Athens, National and Kapodistrian University of Athens, Athens 18233, Greece
Dimitrios V Moysidis, Hippokration University Hospital, Aristotle University of Thessaloniki, Thessaloniki 54642, Greece
Andreas S Papazoglou, Athens Naval Hospital, Athens 18233, Greece
Marios Papadakis, Department of Surgery II, University Hospital Witten-Herdecke, University of Witten-Herdecke, Wuppertal 42283, Germany
Author contributions: Tsagkaris C conceptualized this letter; Tsagkaris C, Papadakos SP and Moysidis DV performed the literature search; Tsagkaris C, Papadakos SP and Papazoglou AS wrote the first draft; Moysidis DV, Koutsogianni A and Papadakis M revised the manuscript and wrote the second draft; All authors have further revised, read and approve the final manuscript.
Conflict-of-interest statement: All authors report no relevant conflict of interest for this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Christos Tsagkaris, MD, Academic Fellow, Public Health and Policy Working Group, Stg European Student Think Tank, Postjeskade 29, 1058 DE, Amsterdam, Netherlands. chriss20x@gmail.com
Received: December 25, 2021 Peer-review started: December 25, 2021 First decision: February 15, 2022 Revised: April 7, 2022 Accepted: June 26, 2022 Article in press: June 26, 2022 Published online: July 22, 2022 Processing time: 204 Days and 12.2 Hours
Abstract
Chronic liver disease can affect many body systems including the musculoskeletal system. The pathogenetic crosstalk between the liver and organs such as the brain and the kidneys has already been described with compound terms merging the organs affected by the pathology, such as the hepatorenal syndrome. Nevertheless, the musculoskeletal manifestations of chronic liver disease have not been coined with such a term to date. Because of this shortage, documenting the musculoskeletal implications of chronic liver disease in both research and clinical practice is challenging. To fill this gap, the authors propose the term hepatomusculoskeletal disorders, a compound term of Greek origin that encompasses all the body structures involved in the aforementioned pathologic crosstalk.
Core Tip: The authors recommend coining the umbrella term “hepatomusculoskeletal disorders” in response to the need to expand knowledge about chronic liver disorders and capitalize it in the form of practice guidelines.
